Aberrant expression of SLC1A3 has been associated with neurological disorders, including hypoxic‐ischaemic brain damage,12, 13, 14 Alzheimer's disease (AD),15 episodic ataxia,16 hemiplegia,17 epilepsy,18 schizophrenia19, 20 and emotional and cognitive abnormalities.21, 22, 23. This evidence concerns the gene SLC1A3 and Alzheimer disease.